These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35231500)

  • 21. Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection.
    Ciccosanti F; Di Rienzo M; Romagnoli A; Colavita F; Refolo G; Castilletti C; Agrati C; Brai A; Manetti F; Botta L; Capobianchi MR; Ippolito G; Piacentini M; Fimia GM
    Antiviral Res; 2021 Jun; 190():105064. PubMed ID: 33781803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release.
    Eymieux S; Rouillé Y; Terrier O; Seron K; Blanchard E; Rosa-Calatrava M; Dubuisson J; Belouzard S; Roingeard P
    Cell Mol Life Sci; 2021 Apr; 78(7):3565-3576. PubMed ID: 33449149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro.
    Ohashi H; Wang F; Stappenbeck F; Tsuchimoto K; Kobayashi C; Saso W; Kataoka M; Yamasaki M; Kuramochi K; Muramatsu M; Suzuki T; Sureau C; Takeda M; Wakita T; Parhami F; Watashi K
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2.
    Plante KS; Dwivedi V; Plante JA; Fernandez D; Mirchandani D; Bopp N; Aguilar PV; Park JG; Tamayo PP; Delgado J; Shivanna V; Torrelles JB; Martinez-Sobrido L; Matos R; Weaver SC; Sastry KJ; Newman RA
    Biomed Pharmacother; 2021 Jun; 138():111457. PubMed ID: 33721754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Interaction of Hypericin with SARS-CoV-2 Reveals a Multimodal Antiviral Activity.
    Delcanale P; Uriati E; Mariangeli M; Mussini A; Moreno A; Lelli D; Cavanna L; Bianchini P; Diaspro A; Abbruzzetti S; Viappiani C
    ACS Appl Mater Interfaces; 2022 Mar; 14(12):14025-14032. PubMed ID: 35302731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia.
    Guisado-Vasco P; Carralón-González MM; Aguareles-Gorines J; Martí-Ballesteros EM; Sánchez-Manzano MD; Carnevali-Ruiz D; García-Coca M; Barrena-Puertas R; de Viedma RG; Luque-Pinilla JM; Sotres-Fernandez G; Fernández-Sousa JM; Luepke-Estefan XE; López-Martín JA; Jimeno JM
    J Hematol Oncol; 2022 Jan; 15(1):4. PubMed ID: 35012608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligomeric assembly of the C-terminal and transmembrane region of SARS-CoV-2 nsp3.
    Babot M; Boulard Y; Agouda S; Pieri L; Fieulaine S; Bressanelli S; Gervais V
    J Virol; 2024 Apr; 98(4):e0157523. PubMed ID: 38483167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Near-Native Visualization of SARS-CoV-2 Induced Membrane Remodeling and Virion Morphogenesis.
    Bergner T; Zech F; Hirschenberger M; Stenger S; Sparrer KMJ; Kirchhoff F; Read C
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lectin from
    Auth J; Fröba M; Große M; Rauch P; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Dolischka A; Prieschl-Grassauer E; Setz C; Schubert U
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses.
    Fomenko VV; Rudometova NB; Yarovaya OI; Rogachev AD; Fando AA; Zaykovskaya AV; Komarova NI; Shcherbakov DN; Pyankov OV; Pokrovsky AG; Karpenko LI; Maksyutov RA; Salakhutdinov NF
    Molecules; 2022 Jan; 27(1):. PubMed ID: 35011529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2
    Gammeltoft KA; Zhou Y; Duarte Hernandez CR; Galli A; Offersgaard A; Costa R; Pham LV; Fahnøe U; Feng S; Scheel TKH; Ramirez S; Bukh J; Gottwein JM
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0268020. PubMed ID: 34097489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photodynamic Inactivation of SARS-CoV-2 Infectivity and Antiviral Treatment Effects In Vitro.
    Ziganshyna S; Szczepankiewicz G; Kuehnert M; Schulze A; Liebert UG; Pietsch C; Eulenburg V; Werdehausen R
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells.
    Ter Ellen BM; Dinesh Kumar N; Bouma EM; Troost B; van de Pol DPI; van der Ende-Metselaar HH; Apperloo L; van Gosliga D; van den Berge M; Nawijn MC; van der Voort PHJ; Moser J; Rodenhuis-Zybert IA; Smit JM
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity.
    Pohl MO; Martin-Sancho L; Ratnayake R; White KM; Riva L; Chen QY; Lieber G; Busnadiego I; Yin X; Lin S; Pu Y; Pache L; Rosales R; Déjosez M; Qin Y; De Jesus PD; Beall A; Yoh S; Hale BG; Zwaka TP; Matsunaga N; García-Sastre A; Stertz S; Chanda SK; Luesch H
    ACS Infect Dis; 2022 Jul; 8(7):1265-1279. PubMed ID: 35766385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle.
    Salgado-Benvindo C; Thaler M; Tas A; Ogando NS; Bredenbeek PJ; Ninaber DK; Wang Y; Hiemstra PS; Snijder EJ; van Hemert MJ
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice.
    Muturi E; Hong W; Li J; Yang W; He J; Wei H; Yang H
    Int J Antimicrob Agents; 2022 Jan; 59(1):106499. PubMed ID: 34929295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 egress from Vero cells: a morphological approach.
    Caldas LA; Carneiro FA; Augusto I; Corrêa IA; da Costa LJ; Miranda K; Tanuri A; de Souza W
    Histochem Cell Biol; 2024 Jan; 161(1):59-67. PubMed ID: 37736815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential Antiviral Options against SARS-CoV-2 Infection.
    Ianevski A; Yao R; Fenstad MH; Biza S; Zusinaite E; Reisberg T; Lysvand H; Løseth K; Landsem VM; Malmring JF; Oksenych V; Erlandsen SE; Aas PA; Hagen L; Pettersen CH; Tenson T; Afset JE; Nordbø SA; Bjørås M; Kainov DE
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32545799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. iPSC screening for drug repurposing identifies anti-RNA virus agents modulating host cell susceptibility.
    Imamura K; Sakurai Y; Enami T; Shibukawa R; Nishi Y; Ohta A; Shu T; Kawaguchi J; Okada S; Hoenen T; Yasuda J; Inoue H
    FEBS Open Bio; 2021 May; 11(5):1452-1464. PubMed ID: 33822489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral effects of human placenta hydrolysate (Laennec
    Kim EH; Kim YI; Jang SG; Im M; Jeong K; Choi YK; Han HJ
    J Microbiol; 2021 Nov; 59(11):1056-1062. PubMed ID: 34613605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.